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In VItro InhIbItIon of MatrIx MetalloproteInases, 
InvasIon and Growth of fanconI aneMIa huMan fanca 
and fancc lyMphoblasts by nutrIent MIxture
M.W. Roomi, B. Bhanap, N.W. Roomi, A. Niedzwiecki*, M. Rath
Dr. Rath Research Institute, Santa Clara CA-95035, USA
Aim: Fanconi anemia is a rare genetic disorder with high propensity for development of cancers, such as aplastic anemia, leukemia 
and head and neck cancers. Collagen digesting matrix metalloproteinase (MMP) enzymes have been implicated in for their role 
in various malignancies and to promote metastasis. Biological agents that prevent extracellular matrix digestion by the MMPs have 
been shown to be promising therapeutic approaches to cancer. In this study, we investigated effects of a nutrient mixture (NM) 
containing, ascorbic acid, lysine, proline and green tea extract, on human FANCA and FANCC lymphoblasts for viability, MMP 
secretion and invasion. Methods: Human FANCA lymphoblasts GM13022 and HCS536 were challenged with NM at concentration 
range within 10–1000 µg/ml. Cell toxicity was assessed by Trypan blue dye exclusion test. Invasion was evaluated through Matri-
gel and gelatinase zymography for MMP activity. Results: NM was toxic in dose dependent mode to HCS536 cells but not 
to GM13022 cells. GM13022 cells but not HCS536 cells exhibited MMP-9 secretion, which was inhibited by NM. Matrigel 
invasion was inhibited in HCS536 cells at 100 and 500 µg/ml by 27% and 93%, respectively. In GM13022 cells, the NM showed 
completely blocked Matrigel invasion at 500 µg/ml. Conclusion: NM inhibited MMP secretion and Matrigel invasion in FANCA 
and inhibited invasion and induced toxicity in FANCC lymphoblasts. These results suggest that the NM may have therapeutic 
potential in Fanconi anemia associated neoplasia.
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Fanconi anemia (FA) is a rare autosomal reces-
sive disorder characterized by bone marrow failure, 
congenital defects, chromosomal instabilities, and 
cancer predisposition. Acute myeloid leukemia 
and head and neck squamous cell carcinomas are 
the major causes of morbidity and mortality in FA pa-
tients. Fifteen FA genes have been identified to date, 
the most prevalent being FANCA, FANCC, FANCG and 
FANCD2 [1]. We have developed strategies to inhibit 
cancer development and its spread using naturally 
occurring nutrients such as lysine, proline, ascorbic 
acid, and green tea extract in a nutrient mixture (NM). 
In our previous studies, the NM has exhibited a broad 
spectrum of pharmacological, therapeutic, cardiovas-
cular, and chemoprotective actions [2–4]. The NM has 
shown synergistic anticancer activity in vivo and in vi-
tro in a number of cancer cell lines through inhibition 
of cancer cell growth, matrix metalloproteinase (MMP) 
secretion, invasion, metastasis, and angiogenesis.
Lymphoblasts derived from FA patients do not show 
the same growth defect manifested in FA fibroblasts. 
Despite the growth differences, the basic FA pheno-
type is expressed in FA lymphoblasts and is sensitive 
to mitomycin C and psoralen plus light [5]. This feature 
prompted us to study the effect of NM on FA lympho-
blasts. In the current study, we examined the effects 
of NM on toxicity, invasion, and MMP expression 
on FA lymphoblasts derived from a FA patient.
The composition of the NM included the  following: 
Vitamin C (as ascorbic acid and as Mg, Ca and palmi-
tate ascorbate) 710 mg; L-Lysine 1,000 mg; L-Proline 
750 mg; L-Arginine 500 mg; N-Acetyl Cysteine 200 mg; 
Standardized Green Tea Extract (80% polyphenol) 
1,000 mg; Selenium 30 µg; Copper 2 mg; and Man-
ganese 1 mg.
Human FANCA lymphoblasts GM13022 and 
FANCC lymphoblasts HCS536 were obtained from 
Dr. Clapp’s and S.L. Siccone’s laboratory at the Her-
man B. Wells Center for Pediatric Research, Indi-
anapolis, IN. The cells were grown in modified 
RPMI supplemented with 15% fetal bovine serum, 
100  U/ ml penicillin, and 100 µg/ml streptomycin (Gibco 
BRL, Long Island, NY) in 24-well tissue culture plates 
(Costar, Cambridge, MA). Cells were incubated with 
1 ml of media at 37 °C in a tissue culture incubator 
equilibrated with 95% air and 5% CO2. At near conflu-
ence, the wells were treated with the NM, dissolved 
in the media and tested with the NM in triplicate at each 
dose within 10–1,000 µg/ml range. Cell cytotoxicity 
was assessed by the trypan blue dye exclusion test 
after 24 hours. To induce MMP-9 secretion, cells were 
also treated with PMA (100 ng/ml)
Invasion studies were conducted as described 
earlier with Matrigel™ (Becton — Dickinson) inserts 
in 24-well plates [6]. The cells were supplemented with 
the NM as specified in the design of the experiment 
and seeded on the insert in the well. Both the me-
dium on the insert and in the well contained the same 
supplements. The plates with the inserts were then 
incubated in a culture incubator equilibrated with 95% 
air and 5% CO2 for 24 hours. After incubation, the me-
dium from the wells was withdrawn. The outer surface 
of the insert was washed and the media and washing 
was collected gently in the well. The media was spun 
and the cells were counted.
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Gelatinase zymography was performed as de-
scribed [6]. In brief, the culture media (20 µl) were 
mixed with the sample buffer and loaded for SDS Poly-
acrylamide Gel Electrophoresis (SDS-PAGE) with tris-
glycine SDS buffer. Samples were not boiled before 
electrophoresis. Following electrophoresis, the gels 
were washed twice in 2.5% Triton X-100 for 30 min 
at room temperature to remove SDS. The gels were 
then incubated at 37 °C overnight in CaCl2 at pH 8.0 and 
stained with 0.5% Coomassie Blue R250 in 50% me-
thanol and 10% glacial acetic acid for 30 min and de-
stained producing clear bands against an intensely 
stained background. Gelatinase zymograms were 
scanned using a CanoScan 9950F Canon scanner 
at 1.200 dpi. The intensity of the bands was evaluated 
using a pixel-based densitometer program  Un-Scan-It, 
Version 5.1, 32-bit (Silk Scientific Corporation), 
at a resolution of 1 Scanner Unit (1/100 dpi), and ex-
pressed as a percentage of control.
The results were expressed as mean ± SD. Data 
was analyzed by independent t-test.
N M  e x h i b i t e d  d o s e - d e p e n d e n t  d e a t h 
o f  H C S 5 3 6  l y m p h o b l a s t  w i t h i n  t h e  ra n g e 
of  10–500 µg/ml (Fig. 1, a) but not GM13022 even 
at the highest concentration (Fig. 1, b).
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fig. 1. Effect of NM on FA lymphoblasts: a — NM was toxic 
to HCS536 lymphoblast growth (p < 0.01); b — NM was not toxic 
to GM13022 lymphoblast growth
G M 13 0 2 2  l y m p h o b l a s t s  e x h i b i t e d  o n l y 
MMP-9 secretion (Fig. 2, a), which was enhanced 
by PMA (100 ng/ml) as shown in Fig. 2, b. NM inhi-
bited MMP-9 secretion 50% at 500 µg/ml, and 90% 
at 1000 µg/ml concentration (Fig. 2, c). In contrast, 
HCS536 lymphoblasts did not demonstrate MMP 
activity, even with PMA stimulation (figure not shown).
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fig. 2. Effect of NM on GM13022 lymphoblasts on MMP se-
cretion: a — untreated cells; b — PMA (100 ng/ml) treated cells 
(Legend: 1 — marker, 2 — control, 3–7 — NM 10, 50, 100, 500, 
1000 µg/ml); c — densitometry analysis of the effect of NM on un-
treated cells shown in a (R2 = 0.8296)
Invasion through Matr igel  was inhibited 
in HCS536 at 100 µg/ml and 500 µg/ml by 27% 
and 93% as shown in Fig. 3. In GM13022 cells, 
the NM had little effect at 50 µg/ml and 100 µg/ml, 
but at 500 µg/ml NM completely blocked the invasion.
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fig. 3. Effect of NM on Matrigel Invasion: a — Matrigel invasion 
of HCS536 lymphoblasts (p < 0.0001); b — GM13022 lympho-
blasts
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Our studies demonstrate that NM was toxic 
to HCS536 cells, inhibited secretion of MMP-9 
in GM13022 and invasion in both FA lymphoblasts.
MMPs have received much attention in recent 
years for their role in various malignancies and have 
been implicated in tumor invasion and metastasis. 
Biological agents that prevent ECM degradation 
by MMPs has shown to be a promising preventative 
approach to cancer.
FANCA mutations are the most prevalent, acco-
unting for approximately two-thirds of all FA cases, 
FANCC and FANCG account for 25% of cases of FA mu-
tations [7]. In addition to predisposition to many types 
of bone marrow disorders, some of these mutations 
are thought to be linked at a molecular level to many 
other DNA damage-repair disorders [8]. The genetic 
defects associated with FA patients are also found 
to be closely related to those of breast cancer with 
BRCA2 mutation [9, 10].
Head and neck squamous cell carcinoma and acute 
myeloid leukemia are the most frequently occurring can-
cers in FA patients. Current treatment methods available 
for FA associated cancers are generally ineffective and 
particularly toxic. Thus, there is a need for development 
of effective therapeutic agents for these cancers with 
minimal toxicity. In a recent study, we demonstrated that 
the NM inhibited MMP expression, invasion, induced 
apoptosis in immortalized FA patient fibroblasts — FA-
A:PD20, FA-A:PD220 cell lines [11]. In another study, 
we have shown that the NM also significantly inhibited 
growth and tumor burden of OHS-947 FA-HNSCC cell 
line in vivo and inhibited proliferation, secretion of MMP 
and Matrigel invasion in vitro [12]. Moreover, in contrast 
to the toxic effects of current chemotherapeutic ap-
proaches, the NM has been shown to be safe in other 
studies [13].
The present study further supports these benefits 
of the NM in FA cells and therefore indicates that 
the NM is a safe and effective approach to support 
FA patients.
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